Anthem Biosciences Complete Financial Statements
ANTHEM • Review detailed financials to uncover trends, confirm thesis & journal trades
6 Years of Data
2025 - 2020
Complete Financial Data Export
Export complete financial statements for Anthem Biosciences (ANTHEM).
Downloads include all available records across all periods.
For market performance, see the
ANTHEM stock price today
.
Profitability Ratios
Net Profit Margin
28.93%
2025 data
EBITDA Margin
44.48%
2025 data
Operating Margin
40.00%
2025 data
Return on Assets
6.16%
2025 data
Return on Equity
7.18%
2025 data
Balance Sheet Ratios
Current Ratio
24.13
2025 data
Debt to Equity
1.17
2025 data
Equity Ratio
85.83%
2025 data
Asset Turnover
0.21
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+8.1%
Year-over-Year
Net Profit Growth
+6.8%
Year-over-Year
EBITDA Growth
+19.3%
Year-over-Year
Expense Growth
+0.6%
Year-over-Year
Assets Growth
+17.1%
Year-over-Year
Equity Growth
+25.2%
Year-over-Year
Liabilities Growth
+17.1%
Year-over-Year
Operating Cash Flow Growth
+198.6%
Year-over-Year
Investing Cash Flow Growth
+31.5%
Year-over-Year
Financing Cash Flow Growth
-74.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Jun 2024 | Dec 2024 |
|---|---|---|---|---|---|---|
| Revenue | 598 | 497 | 563 | 553 | 358 | 522 |
| Expenses | 332 | 288 | 349 | 330 | 218 | 338 |
| EBITDA | 266 | 209 | 214 | 223 | 140 | 184 |
| Operating Profit Margin % | 40.00% | 40.00% | 35.00% | 37.00% | 36.00% | 32.00% |
| Depreciation | 34 | 30 | 27 | 20 | 19 | 20 |
| Interest | 3 | 1 | 2 | 4 | 4 | 3 |
| Profit Before Tax | 230 | 178 | 186 | 200 | 118 | 161 |
| Tax | 56 | 96 | 51 | 38 | 36 | 37 |
| Net Profit | 173 | 83 | 136 | 162 | 82 | 124 |
| Earnings Per Share (₹) | 3.09 | 1.48 | 2.43 | 2.90 | 1.47 | 2.22 |
Related Pages for Anthem Biosciences
Additional stock information and data for ANTHEM
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 2,808 | 2,398 | 2,015 | 1,619 | 1,034 | 787 |
| Current Assets | 1,737 | 1,482 | 1,323 | 1,098 | 616 | 403 |
| Fixed Assets | 705 | 483 | 449 | 329 | 361 | 306 |
| Capital Work in Progress | 297 | 345 | 164 | 154 | 19 | 50 |
| Investments | 433 | 472 | 499 | 273 | 209 | 99 |
| Other Assets | 1,373 | 1,099 | 903 | 863 | 445 | 333 |
| LIABILITIES | ||||||
| Total Liabilities | 2,808 | 2,398 | 2,015 | 1,619 | 1,034 | 787 |
| Current Liabilities | 72 | 135 | 110 | 41 | 47 | 118 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 2,410 | 1,925 | 1,741 | 1,355 | 702 | 422 |
| Share Capital | 112 | 112 | 114 | 9 | 9 | 8 |
| Reserves & Surplus | 2,298 | 1,813 | 1,627 | 1,346 | 693 | 414 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | 418 | 140 | 306 | 333 | 278 | 166 |
| Investing Activities | -152 | -222 | -376 | -205 | -196 | -109 |
| Financing Activities | -134 | -77 | 64 | 181 | -63 | -48 |
| Net Cash Flow | 133 | -159 | -6 | 308 | 18 | 9 |